Literature DB >> 12788500

Open space swimming test to index antidepressant activity.

Miao-Kun Sun1, Daniel L Alkon.   

Abstract

Depression is characterized by a lack of "motivation" rather than a lack of "physical space" to move around. This study was designed to evaluate predictivity of an open space swimming test for antidepressant activity of various antidepressants in rats. Without drug treatment, rats showed a significant reduction in the distance moved (increased immobility) over successive trials in an open space water pool. Three major classes of antidepressants and a selective serotonin reuptake inhibitor (SSRI) were tested. Repeated treatment (10 mg/kg x 3 per day) of imipramine, a prototypical tricyclic antidepressant, iproniazid, a monoamine oxidase inhibitor, mianserin, an atypical antidepressant, and alaproclate, an SSRI, all significantly reduced the immobility. These results suggest that the open space swimming test is highly predictive of antidepressant action and is more sensitive to the drug treatments. The measurement is more objective than that of the forced swimming test and does not involve judging and scoring the animals' movement or lack of movement by investigators. The demonstrated effectiveness of three major types of antidepressants and an SSRI suggests that the effects on the test are not restricted to a particular underlying molecular mechanism of action. Thus, this swimming test shows promising potential as a screen for novel antidepressants and, perhaps, for revealing some of the underlying pathophysiology of depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788500     DOI: 10.1016/s0165-0270(03)00068-2

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  Open-space forced swim model of depression for mice.

Authors:  Eric A Stone; Yan Lin
Journal:  Curr Protoc Neurosci       Date:  2011-01

2.  Structural changes and neurotrophic factors upregulation in submandibular gland in a rat model of depression: proposed correlation with stress indicators during and after the relief of depression.

Authors:  Magda A Eldomiaty; Zeinab A Hassan; Amal M Halawa; Abdelrahman M Elnajar; Nawal Almohamadi
Journal:  Anat Sci Int       Date:  2022-10-01       Impact factor: 1.693

Review 3.  Toward an animal model of extinction-induced despair: focus on aging and physiological indices.

Authors:  Joseph P Huston; Daniela Schulz; Bianca Topic
Journal:  J Neural Transm (Vienna)       Date:  2009-04-07       Impact factor: 3.575

4.  Evaluation of the repeated open-space swim model of depression in the mouse.

Authors:  Eric A Stone; Yan Lin; David Quartermain
Journal:  Pharmacol Biochem Behav       Date:  2008-07-19       Impact factor: 3.533

5.  Protective Effects of Forskolin on Behavioral Deficits and Neuropathological Changes in a Mouse Model of Cerebral Amyloidosis.

Authors:  Brice Ayissi Owona; Caroline Zug; Hermann J Schluesener; Zhi-Yuan Zhang
Journal:  J Neuropathol Exp Neurol       Date:  2016-05-31       Impact factor: 3.685

6.  Intravenous Administration of Human Amniotic Mesenchymal Stem Cells in the Subacute Phase of Cerebral Infarction in a Mouse Model Ameliorates Neurological Disturbance by Suppressing Blood Brain Barrier Disruption and Apoptosis via Immunomodulation.

Authors:  Yasunori Yoshida; Toshinori Takagi; Yoji Kuramoto; Kotaro Tatebayashi; Manabu Shirakawa; Kenichi Yamahara; Nobutaka Doe; Shinichi Yoshimura
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

7.  A DKP cyclo(L-Phe-L-Phe) found in chicken essence is a dual inhibitor of the serotonin transporter and acetylcholinesterase.

Authors:  Nobuo Tsuruoka; Yoshinori Beppu; Hirofumi Koda; Nobutaka Doe; Hiroshi Watanabe; Keiichi Abe
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

8.  Stress-induced alterations of social behavior are reversible by antagonism of steroid hormones in C57/BL6 mice.

Authors:  Benedikt Andreas Gasser; Johann Kurz; Walter Senn; Genevieve Escher; Markus Georg Mohaupt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-09-07       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.